2026 NPPES data MOHS-Micrographic Surgery Physician NPI 1538191846 M.D.
Verify on CMS →

MARK LISKA, M.D.

MOHS-Micrographic Surgery Physician in NORTH FALMOUTH, Massachusetts. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
1K
Medicare Part D claims · 471 beneficiaries · MOHS-Micrographic Surgery Physician avg: 607
Generic prescribing
91%
generic claims · 9% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
75/100
▼ 8 pts below national avg 83.1 · [object Object]
Industry payments
$80.04
4 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: MARK LISKA, M.D. is a MOHS-Micrographic Surgery Physician ([object Object]) practicing in NORTH FALMOUTH, Massachusetts with a Medicare Part D prescribing footprint of 1K claims across 471 beneficiaries — 9% brand-name prescribing . Their CMS MIPS Final Score of 75/100 (national average: 83.1) reflects performance across Quality, Cost, Interoperability, and Improvement Activities . Industry payments of $80.04 across 4 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: MARK LISKA, M.D. reported a CMS MIPS final score of 75 out of 100, below the 83.1 national average, and filed 1,029 Medicare Part D claims in 2023. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board certification likely (heuristic — not verified)

MARK LISKA, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

MARK LISKA, M.D. at a glance

Below national average

NPI registry status

Active

Issued 07/07/2006

NPI 1538191846

Primary specialty

MOHS-Micrographic Surgery Physician

Niche

1,102 US NPIs in this specialty

Medicare Part D claims

1,029 70% vs specialty avg

2023 prescription claims

Specialty avg: 607

MIPS final score

75/100 8.099999999999994% pts

Above neutral band

vs 83.1 national avg

Specialty distribution in Massachusetts

How MOHS-Micrographic Surgery Physician compares to other specialties among Massachusetts providers

Massachusetts providers

MOHS-Micrographic Surgery Physician share within Massachusetts

1. MOHS-Micrographic Surgery Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
MOHS-Micrographic Surgery Physician share within Massachusetts

Medicare quality performance — MIPS

MARK LISKA, M.D.'s 2023 MIPS final score plotted against the MOHS-Micrographic Surgery Physician national average

Below national average
MIPS Final Score
75/100
vs 83.1 national avg · 2023 performance year

MIPS final score (MOHS-Micrographic Surgery Physician) — 75/100 vs national avg 83.1

0%100%National avg83%75%
MIPS final score (MOHS-Micrographic Surgery Physician) — 75/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MARK LISKA, M.D. is a MOHS-Micrographic Surgery Physician provider practicing in NORTH FALMOUTH, Massachusetts, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: M.D.. NPI: 1538191846. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

MARK LISKA, M.D. appears in the CMS NPPES registry as a MOHS-Micrographic Surgery Physician provider holding M.D. credentials at 37 EDGERTON DRIVE, NORTH FALMOUTH, MA, 02556, with a listed phone of (508) 563-2550. NPI 1538191846 was issued on 07/07/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what LISKA most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 1,029 prescription claims written by this provider, covering 471 Medicare beneficiaries and totaling roughly $835K in drug spend, split 9% brand-name and 91% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 75/100 for the 2023 performance year, compared with the national average of 83.1.

MOHS-Micrographic Surgery Physician is a narrow specialty nationwide, with 1,102 enrolled providers across 52 states and an average of 607 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

37 EDGERTON DRIVE
NORTH FALMOUTH, MA 02556

Provider Details

NPI 1538191846
Specialty MOHS-Micrographic Surgery Physician
Credentials M.D.
Gender Male
NPI Issued 07/07/2006

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

75
Final Score
Avg: 83.1

Reporting: Group practice

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MARK LISKA, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$80

Largest payer

Dermavant Sciences, Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Massachusetts BORIM 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~38K Massachusetts medical licensees in 2023 — they are NOT specific to MARK LISKA, M.D.. To verify MARK LISKA, M.D.'s current license status, search the BORIM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

80
Total board actions, Massachusetts 2023
Across 78 cases
2.11
Actions per 1,000 licensees
Massachusetts statewide rate
probation
Most common action type
29 cases

BORIM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Massachusetts disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Generic-heavy

MARK LISKA, M.D. — brand share 9.0%
Specialty average (est.)

9% brand-name claims vs 91% generic, on 1,029 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

1,029
Total Claims
$835K
Total Drug Cost
471
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,305
Total Day Supply
35,407
Brand vs Generic
9% brand / 91% generic
Brand Drug Cost
$798K
Generic Drug Cost
$37K
Antibiotic Claims
104

Patient Demographics

Average Patient Age
78.6 years
Avg HCC Risk Score
1.14
Gender Split
48% female / 52% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Triamcinolone Acetonide
175
Fluorouracil
152
Betamethasone Diprop Augmented
Betamethasone/Propylene Glyc
104
Clobetasol Propionate
59
Valacyclovir
Valacyclovir Hcl
55
Doxycycline Monohydrate
45
Mupirocin
31
Prednisone
25
Skyrizi Pen
Risankizumab-Rzaa
23
Sulfamethoxazole-Trimethoprim
Sulfamethoxazole/Trimethoprim
23

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

MOHS-Micrographic Surgery Physician Overview

How MARK LISKA, M.D. fits within the MOHS-Micrographic Surgery Physician landscape nationally.

1,102
MOHS-Micrographic Surgery Physician Providers in US
52
States with MOHS-Micrographic Surgery Physician
607
Avg Claims per Provider

MARK LISKA, M.D.'s 1,029 claims are above the specialty average of 607.

Nearby MOHS-Micrographic Surgery Physician Providers in Massachusetts

Other clinicians with the same primary specialty enrolled in Massachusetts, drawn from the same CMS NPPES roster as LISKA.

Compare MOHS-Micrographic Surgery Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is MARK LISKA, M.D.'s specialty?
MARK LISKA, M.D. specializes in MOHS-Micrographic Surgery Physician and practices in NORTH FALMOUTH, Massachusetts. Credentials: M.D..
How much does MARK LISKA, M.D. prescribe under Medicare Part D?
In 2023, MARK LISKA, M.D. wrote 1,029 Medicare Part D claims totaling $835K in drug costs for 471 beneficiaries.
What is MARK LISKA, M.D.'s Medicare quality score?
MARK LISKA, M.D. has a CMS MIPS Final Score of 75/100. The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is MARK LISKA, M.D. located?
MARK LISKA, M.D. is located at 37 EDGERTON DRIVE, NORTH FALMOUTH, MA, 02556. Phone: (508) 563-2550.
What is MARK LISKA, M.D.'s NPI number?
MARK LISKA, M.D.'s National Provider Identifier (NPI) is 1538191846, issued on 07/07/2006.
Does MARK LISKA, M.D. prescribe more brand-name or generic drugs?
MARK LISKA, M.D.'s prescribing is 9% brand-name and 91% generic drugs by claim count, with $798K in brand drug costs.
How many MOHS-Micrographic Surgery Physician providers are there in the US?
There are 1,102 MOHS-Micrographic Surgery Physician providers across 52 states in the US. The average MOHS-Micrographic Surgery Physician provider writes 607 Medicare Part D claims per year.
What drugs does MARK LISKA, M.D. prescribe most often?
Based on 2023 Medicare Part D data, MARK LISKA, M.D.'s most frequently prescribed drugs include Triamcinolone Acetonide, Fluorouracil, Betamethasone Diprop Augmented. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MARK LISKA, M.D. accept Medicare?
MARK LISKA, M.D. appears in CMS Medicare data with 1,029 Part D claims and 471 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MARK LISKA, M.D.'s credentials?
MARK LISKA, M.D.'s NPI is 1538191846 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology